Data / Research funding / Texas / University of Texas HLTH CTR at Tyler
University of Texas HLTH CTR at Tyler: 31 NIH awards ($25.3M) and 2 NSF awards ($487.5K), fiscal years 2021 to 2026
University of Texas HLTH CTR at Tyler in Tyler, TX is funded under 31 NIH awards ($25.3M) and 2 NSF awards ($487.5K) in the NIH and NSF award files, read 2026-11-04. NIH fiscal years 2021 to 2025; NSF fiscal years 2022 to 2026.
SpecStream is the live web data engine for teams and agents. It reads the NIH and NSF award files each time the agencies update them, and this page is that reading, joined to the open federal funding opportunities on Grants.gov. Ask for the awards you track by topic, organization or state and new awards arrive in your sheet, CRM, Slack or agent as the agencies publish them.
- UEI
- FPCUDWBE7DX2
- State
- Texas
Awards
33 awards in the window.
| Award | Agency | Institute or division | Fiscal year | Amount in window | Start | End | Principal investigator | Source |
|---|---|---|---|---|---|---|---|---|
| Enhanced Delivery of Thrombolytic Carriers for Empyema | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,499,662 | July 15, 2021 | June 30, 2026 | KOMISSAROV, ANDREY | reporter.nih.gov |
| Delivery of PAI-1-targeted intrapleural fibrinolytic therapy for empyema | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $2,141,932 | September 1, 2017 | March 31, 2026 | KOMISSAROV, ANDREY | reporter.nih.gov |
| Development, Formulation and Inhalational Delivery of a New Peptide for ILD | NIH | National Heart, Lung, and Blood Institute | 2021 to 2024 | $1,796,712 | December 15, 2020 | November 30, 2025 | SHETTY, SREERAMA | reporter.nih.gov |
| Innate immune response of LTBI+HIV+ children | NIH | National Institute of Allergy and Infectious Diseases | 2021 to 2024 | $1,390,281 | September 14, 2020 | February 18, 2024 | VANKAYALAPATI, RAMAKRISHNA | reporter.nih.gov |
| Membrane Phospholipids: The Key Regulators of Tissue Factor Encryption/Decryption | NIH | National Heart, Lung, and Blood Institute | 2021 to 2023 | $1,371,099 | September 1, 2015 | April 30, 2026 | LELLA, VIJAYA MOHAN RAO | reporter.nih.gov |
| Factor VIIa-released extracellular vesicles: Their role in hemostasis and beyond | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,357,616 | March 15, 2024 | February 29, 2028 | LELLA, VIJAYA MOHAN RAO | reporter.nih.gov |
| The Role of Gab2-MALT1-mediated cell signaling in venous thrombogenesis | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $1,227,432 | July 15, 2024 | April 30, 2028 | LELLA, VIJAYA MOHAN RAO | reporter.nih.gov |
| Short course combination regimens for treatment of Mycobacterium avium pulmonary disease: a translational bench-to-bedside approach | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $1,125,824 | December 8, 2023 | October 31, 2028 | KANT, SHASHI | reporter.nih.gov |
| The role of conformational dynamics of enveloped virus spike proteins in cell entry | NIH | National Institute of General Medical Sciences | 2023 to 2025 | $1,117,500 | September 1, 2023 | August 31, 2028 | LU, MAOLIN | reporter.nih.gov |
| Myocardin in the pathogenesis of pleural remodeling | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $951,132 | July 1, 2019 | June 30, 2024 | IKEBE, MITSUO | reporter.nih.gov |
| RUNX3 in Vascular Wall Remodeling | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $938,871 | January 5, 2024 | December 31, 2028 | GUO, XIA | reporter.nih.gov |
| PK/PD Optimized Cephalosporins Based Treatment Regimens for Children With MDR-TB | NIH | Eunice Kennedy Shriver National Institute of Child Health & Human Development | 2021 to 2023 | $918,678 | September 1, 2019 | July 31, 2025 | KANT, SHASHI | reporter.nih.gov |
| Probing real-time conformational dynamics and allosteric cooperativity of the HIV-1 envelope glycoprotein during virus entry | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $880,911 | December 1, 2023 | October 31, 2028 | LU, MAOLIN | reporter.nih.gov |
| D0CK2 in pleural fibrosis | NIH | National Heart, Lung, and Blood Institute | 2024 to 2025 | $841,469 | March 1, 2024 | February 29, 2028 | QIAN, GUOQING | reporter.nih.gov |
| Novel CRISPR-Cas9 protein delivery to T cells in vivo by targeting CD7 | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $669,671 | August 20, 2019 | July 31, 2024 | YI, GUOHUA | reporter.nih.gov |
| Concurrent targeting of inflammation and the inhibition of the fibrinolytic system to increase the efficacy of empyema treatment | NIH | National Heart, Lung, and Blood Institute | 2025 | $499,585 | July 15, 2025 | June 30, 2027 | KOMISSAROV, ANDREY | reporter.nih.gov |
| Dedicator of cytokinesis 2 in atherosclerosis | NIH | National Heart, Lung, and Blood Institute | 2021 to 2022 | $498,000 | May 15, 2020 | April 30, 2024 | GUO, XIA | reporter.nih.gov |
| Novel exosomal niches for alveolar stem cell-based repair of ARDS | NIH | National Heart, Lung, and Blood Institute | 2022 | $469,701 | September 1, 2017 | April 30, 2023 | JI, HONG-LONG | reporter.nih.gov |
| Optimization of a Rabbit Retained Hemothorax Model for Evidence-Based Pharmacologic Interventions | NIH | National Heart, Lung, and Blood Institute | 2021 | $440,243 | August 15, 2020 | July 31, 2023 | IDELL, STEVEN | reporter.nih.gov |
| Role of Runx3 in the Regulation of Lung cDC2 by Influenza Infection | NIH | National Institute of Allergy and Infectious Diseases | 2024 to 2025 | $409,750 | June 14, 2024 | April 30, 2027 | TANG, HUA | reporter.nih.gov |
| Distinct responses of lung macrophages and airway epithelial cells to Hawai'i-derived volcanic ash and nontuberculous mycobacteria | NIH | National Institute of Allergy and Infectious Diseases | 2023 to 2024 | $408,249 | March 22, 2023 | February 28, 2026 | HONDA, JENNIFER R. | reporter.nih.gov |
| Regulation of Silica-induced Lung Injury by Plasminogen Activator Inhibitor-1 | NIH | National Institute of Environmental Health Sciences | 2022 | $404,250 | September 20, 2022 | August 31, 2025 | SHETTY, SREERAMA | reporter.nih.gov |
| Tissue Factor's Role in the Pathogenesis of Hypercoagulability in COVID-19 | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $404,250 | March 1, 2022 | February 28, 2026 | LELLA, VIJAYA MOHAN RAO | reporter.nih.gov |
| The Role of Gab2 Signaling in Thromboinflammation | NIH | National Institute of Allergy and Infectious Diseases | 2022 to 2023 | $404,250 | February 10, 2022 | January 31, 2026 | LELLA, VIJAYA MOHAN RAO | reporter.nih.gov |
| Probing conformational dynamics of HIV-1 Env in real time and in situ during virus entry | NIH | National Institute of Allergy and Infectious Diseases | 2022 | $370,700 | August 1, 2022 | July 31, 2024 | LU, MAOLIN | reporter.nih.gov |
| Dedicator of cytokinesis 2 in pleural fibrosis | NIH | National Heart, Lung, and Blood Institute | 2022 | $362,800 | September 15, 2022 | February 29, 2024 | QIAN, GUOQING | reporter.nih.gov |
| Fibrinolytic Proteases, meso-mesenchymal transition and pleural remodeling | NIH | National Heart, Lung, and Blood Institute | 2021 | $362,500 | January 1, 2017 | August 31, 2023 | TUCKER, TORRY ALLE | reporter.nih.gov |
| Characterization of Mechanisms of Exercise Intolerance in Patients at Risk for Heart Failure with Preserved Ejection Fraction | NIH | National Heart, Lung, and Blood Institute | 2023 to 2025 | $344,635 | March 6, 2023 | February 29, 2028 | BERRY, JARETT D | reporter.nih.gov |
| RAPID: Exposure risk for cyclone-induced flooding and bacterial pathogen emergence | NSF | Organismal Interactions & Ecology | 2026 | $287,516 | July 15, 2026 | June 30, 2027 | Jennifer R Honda | nsf.gov |
| Lipoprotein Corona Fingerprints: Implications for Pulmonary Clearance and Toxicity of Engineered Nanoparticles | NIH | National Institute of Environmental Health Sciences | 2021 | $249,000 | March 1, 2019 | August 31, 2022 | KONDURU VENKATA, NAGARJUN | reporter.nih.gov |
| CSP7 inhibits toxicity of ionizing radiation to the lung | NIH | National Cancer Institute | 2025 | $219,024 | July 1, 2025 | June 30, 2027 | SHETTY, SREERAMA | reporter.nih.gov |
| RAPID: Investigating risk for environmentally acquired nontuberculous mycobacterial lung infections in the wake of the Lahaina, Maui wildfires | NSF | Division Of Environmental Biology | 2024 | $200,000 | December 1, 2023 | November 30, 2025 | Jennifer R Honda | nsf.gov |
| Reinforcing old warriors to treat Mycobacterium kansasii in shorter duration | NIH | National Institute of Allergy and Infectious Diseases | 2021 | $188,120 | September 1, 2020 | August 31, 2023 | KANT, SHASHI | reporter.nih.gov |
Funding by fiscal year
| Fiscal year | NIH awards | NIH amount | NSF awards | NSF amount |
|---|---|---|---|---|
| 2026 | 0 | $0 | 1 | $287,516 |
| 2025 | 11 | $4,470,554 | 0 | $0 |
| 2024 | 14 | $5,764,927 | 1 | $200,000 |
| 2023 | 10 | $3,518,725 | 0 | $0 |
| 2022 | 14 | $5,763,957 | 0 | $0 |
| 2021 | 13 | $5,745,684 | 0 | $0 |
Open federal funding opportunities
From Grants.gov: notices that funded awards in this table, and open notices on the same agency and assistance listing.
| Open opportunity | Number | Agency | Listing | Closes | Award ceiling | Why it matches |
|---|---|---|---|---|---|---|
| Infectious Diseases Clinical Trials Network (IDCTN) (UM1 Clinical Trial Required) | RFA-AI-27-002 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 10 awards here |
| Clinical Research Network on Antimicrobial Resistance (UM1 Clinical Trial Required) | RFA-AI-27-005 | NIH | 93.855 | November 10, 2026 | Not listed | Same assistance listing 93.855 as 10 awards here |
| Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional) | PAR-25-370 | NIH | 93.855 | November 16, 2026 | $50,000 | Same assistance listing 93.855 as 10 awards here |
| Ethical, Legal and Social Implications (ELSI) Exploratory/Developmental Research Grant (R21 Clinical Trial Optional) | PAR-25-369 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 10 awards here |
| Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional) | PAR-25-371 | NIH | 93.855 | November 18, 2026 | Not listed | Same assistance listing 93.855 as 10 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Required) | PAR-24-295 | NIH | 93.838 | December 3, 2026 | Not listed | Same assistance listing 93.838 as 10 awards here |
| Emerging Global Leader Award (K43 Independent Clinical Trial Not Allowed) | PAR-24-296 | NIH | 93.838 | December 3, 2026 | Not listed | Same assistance listing 93.838 as 10 awards here |
| NIH Research Software Engineer (RSE) Award (R50 Clinical Trials Not Allowed) | RFA-OD-24-011 | NIH | 93.838 | December 4, 2026 | Not listed | Same assistance listing 93.838 as 10 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R43/R44 Clinical Trial Optional) | PAR-27-039 | NIH | 93.838 | January 5, 2027 | Not listed | Same assistance listing 93.838 as 10 awards here |
| Small Business Transition Grant for New Entrepreneurs (Parent R41/R42 Clinical Trial Optional) | PAR-27-040 | NIH | 93.838 | January 5, 2027 | Not listed | Same assistance listing 93.838 as 10 awards here |
| Academic Research Enhancement Award (AREA) for Undergraduate-Focused Institutions (R15 Clinical Trial Required) | PAR-24-214 | NIH | 93.838 | January 7, 2027 | $375,000 | Same assistance listing 93.838 as 10 awards here |
| Intervention Research to Improve Native American Health (R01 Clinical Trial Optional) | PAR-25-379 | NIH | 93.838 | January 7, 2027 | Not listed | Same assistance listing 93.838 as 10 awards here |
| HIV/AIDS Clinical Trials Network Leadership and Operations Centers | RFA-AI-28-001 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 10 awards here |
| HIV/AIDS Clinical Trials Network Laboratory Centers | RFA-AI-28-002 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 10 awards here |
| HIV/AIDS Clinical Trials Network Statistical and Data Management Centers | RFA-AI-28-003 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 10 awards here |
| HIV/AIDS Clinical Trials Network Clinical Trials Units | RFA-AI-28-004 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 10 awards here |
| Precision and Systems Biology to Uncover the Link Between Chronic and Infectious Diseases | RFA-AI-28-014 | NIH | 93.855 | January 22, 2027 | Not listed | Same assistance listing 93.855 as 10 awards here |
| Immune Tolerance Network (UM1 Clinical Trial Required) | RFA-AI-28-005 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 10 awards here |
| Translational Centers Using Microphysiological Systems for Infectious Diseases (U54 Clinical Trial Not Allowed) | RFA-AI-28-012 | NIH | 93.855 | January 29, 2027 | Not listed | Same assistance listing 93.855 as 10 awards here |
| NHLBI Early Phase Clinical Trials for Therapeutics and/or Diagnostics for HLBS Disorders (R33 CT Required) | PAR-25-025 | NIH | 93.838 | February 3, 2027 | $1.5 million | Same assistance listing 93.838 as 10 awards here |
Topics of its NIH awards
- Lung
- Infectious Diseases
- Rare Diseases
- Clinical Research
- Hematology
- Cardiovascular
- Emerging Infectious Diseases
- Orphan Drug
- Biodefense and Related Countermeasures
- Prevention
- Biotechnology
- Translational Research
Updated November 4, 2026. Read from NIH RePORTER ExPORTER and NSF Award Search. Published by NIH and NSF as U.S. government data. NIH awards are fiscal years 2021 to 2025 (NIH files published to 2026-07-09); NSF awards are fiscal years 2022 to 2026 (NSF files published to 2026-11-04). NIH amounts are the total cost of each fiscal year in the window; NSF amounts are the funds obligated in the window. Organizations are matched on the UEI. Open opportunities come from Grants.gov and match on agency and assistance listing number, and on the notice number NIH prints on an award. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.